NAV3 and colorectal carcinoma: Finally, future studies should include knockout or overexpression of the TCONS_00008997, XR-925056.2 circRNA_07908, and hsa-miR-3182 ncRNAs and the NAV3 and DCBLD2 mRNAs to validate these results using molecular methods and to further confirm the main targets of GA-Me in CRC treatment.